Litigation Insights
The Litigation blog offers insights regarding significant trial cases, arbitration, appeals and dispute resolution.
The Litigation blog offers insights regarding significant trial cases, arbitration, appeals and dispute resolution.
Reflecting a trend of increased scrutiny, on March 8, 2017, the U.S. Food and Drug Administration (FDA) posted two new Warning Letters providing important guidance on statements in cosmetics labeling and marketing amounting to the assertion of "drug claims."